Vanda Pharmaceuticals buy StockNews.com
Start price
04.03.23
/
50%
€5.90
Target price
04.03.24
-
Performance (%)
-34.24%
End price
05.03.24
€3.88
Summary
This prediction ended on 05.03.24 with a price of €3.88. Massive losses of -34.24% were the result for the BUY prediction by StockNews_com. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vanda Pharmaceuticals | -1.613% | -1.613% | 47.343% | -3.175% |
| iShares Core DAX® | 2.489% | -5.941% | 2.896% | 45.717% |
| iShares Nasdaq 100 | 1.649% | -2.462% | 15.754% | 73.262% |
| iShares Nikkei 225® | 0.555% | -7.597% | 30.353% | 48.769% |
| iShares S&P 500 | 1.347% | -2.943% | 10.338% | 55.803% |
Comments by StockNews_com for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for VNDA provided by MarketBeat
In the thread Trading Vanda Pharmaceuticals
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten